article thumbnail

Digitalising drug discovery

pharmaphorum

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

We are doing that with a good number of rare diseases already both in respiratory diseases and neurology with different life sciences companies in different countries.”. BREATHE’s Jenni Quint said that the power is not just in information from wearables but the ability to link them with other data. About BREATHE.

Big Data 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Informatics: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 63
article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including business development, sales and marketing, and people.

article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.

Genome 104
article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

By extracting and reading unstructured information buried within the free text of clinical notes, Savana’s technology and clinical research methodology is enabling clinicians and health researchers around the world to analyse vast amounts of previously inaccessible clinical data. “We Fragmentation of information is our enemy.

Doctors 113
article thumbnail

New technologies fuel advancements in digital health

Pharmaceutical Technology

Services such as Personal Health Records and diagnostic apps collect, store and analyse patient data, which assists healthcare practitioners with diagnosis as well as enabling them to create tailored treatment plans based on the needs of the patient. Hamilton: Canada’s emerging leader in life sciences research and commercialization.